Shan Dong Kexing Bioproducts Co (SHSE:688136) Scaled Net Operating Assets : 0.75 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shan Dong Kexing Bioproducts Co's operating assets for the quarter that ended in Mar. 2024 was ¥2,522 Mil. Shan Dong Kexing Bioproducts Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥247 Mil. Shan Dong Kexing Bioproducts Co's Total Assets for the quarter that ended in Dec. 2023 was ¥3,031 Mil. Therefore, Shan Dong Kexing Bioproducts Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.75.

Shan Dong Kexing Bioproducts Co Scaled Net Operating Assets Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Scaled Net Operating Assets Chart

Shan Dong Kexing Bioproducts Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.92

0.91

0.68

0.73

0.69

Shan Dong Kexing Bioproducts Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.68	0.73	0.71	0.69	0.75

Competitive Comparison of Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets falls into.

Shan Dong Kexing Bioproducts Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2462.297	-	284.238)	/	3164.699
=	0.69

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3031.093	-	568.796
=	2462.297

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1400.298	-	713.625	-	402.435
=	284.238

Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(2521.582	-	246.965)	/	3031.093
=	0.75

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3063.871	-	542.289
=	2521.582

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1439.999	-	655.045	-	537.989
=	246.965

Shan Dong Kexing Bioproducts Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200

Website

http://www.kexing.com

Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.

Executives

Wang Xiao Qin	Directors, senior managers
Cui Ning	Directors, senior managers
Ma Hong Jie	senior management
Shao Ke	senior management
Deng Xue Qin	Director
Zhao Yan Qing	Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines